Interestingly, the CDK9 inhibitor and CDK9 degrader have been compared using MOLT4, a cell line derived from acute lymphoblastic leukemia, inducing apoptosis upon administration of both compounds. Here, CDK9 is linked to acute lymphoblastic leukemia.